Unicorn India Ventures

Unicorn India Ventures is a Mumbai-based early-stage fund deploying $250k-$1M cheques across pre-seed, seed, and Series A into Indian technology startups, with healthcare exposure concentrated in digital health and health IT software. The firm runs a generalist tech thesis with selective conviction bets, and its partners maintain solid networks across Mumbai’s family office and HNI capital base, which can be useful for follow-on syndication. For founders, Unicorn India is best positioned as an early institutional cheque that helps validate a round and bridges to larger Series A leads. The right founder profile is an Indian operator building B2B health software, telemedicine, or workflow automation with early paid customers, founder-market fit, and capital efficiency credentials. Founders raising $5M+ rounds, deep biotech plays, or international teams without India operating presence should not approach. The cleanest intro is via a Unicorn India portfolio CEO, Mumbai’s startup founder community, or warm introductions from family offices that LP into the fund. In the pitch, lead with capital efficiency, ARR or revenue traction, founder-market fit, and a credible Series A narrative; the partners value disciplined operators over hype-driven storytelling. Caveats: Unicorn India is not an AI-thesis fund, so AI-heavy diligence will rely on external advisors. The fund’s brand carries moderate signaling weight in India and limited weight internationally, so founders planning to raise from US or SEA investors at Series A should pair Unicorn India with a co-lead that has cross-border credibility. Reserves and follow-on policy vary by vintage, so request a recent deal sheet and confirm cheque pacing in initial diligence.